MARÍA ISABEL
TEJADA MÍNGUEZ
Forscherin bis um 2019
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de la Santa Creu i Sant Pau (12)
2015
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361
-
L-acetylcarnitine for treating fragile X syndrome
Cochrane Database of Systematic Reviews, Vol. 2015, Núm. 5
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754
-
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research and Treatment, Vol. 119, Núm. 1, pp. 221-232
2009
-
Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
Breast Cancer Research and Treatment, Vol. 113, Núm. 3, pp. 545-551
-
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci
American Journal of Human Genetics, Vol. 84, Núm. 2, pp. 115-122
2008
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869
2007
-
Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer
Breast Cancer Research and Treatment, Vol. 103, Núm. 1, pp. 103-107
2001
1994
-
Identification by molecular diagnosis of mosaic Turner's syndrome in an obligate carrier female for fragile X syndrome
Journal of Medical Genetics, Vol. 31, Núm. 1, pp. 76-78